2023
DOI: 10.1007/s13258-023-01413-6
|View full text |Cite
|
Sign up to set email alerts
|

Identification and validation of an ECM organization-related gene signature as a prognostic biomarker and therapeutic target for glioma patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…ECM regulators such as COL5A3, ECM1, TNXB, COL13A1, SERPINE1, TGFB1, and BMP2 were all upregulated on stiff matrices as compared to the soft ones. 39 Additionally, lysyl oxidase (LOX) family genes, including LOX, LOXL1, and LOXL2, and matrix metalloproteinases (MMPs), including MMP1, MMP7, and MMP9, were also upregulated in spheroids cultured in stiff substrates. The LOX family proteins are major molecules contributing to matrix cross-linking, which is critical for stiffening cancer tissue.…”
Section: Resultsmentioning
confidence: 99%
“…ECM regulators such as COL5A3, ECM1, TNXB, COL13A1, SERPINE1, TGFB1, and BMP2 were all upregulated on stiff matrices as compared to the soft ones. 39 Additionally, lysyl oxidase (LOX) family genes, including LOX, LOXL1, and LOXL2, and matrix metalloproteinases (MMPs), including MMP1, MMP7, and MMP9, were also upregulated in spheroids cultured in stiff substrates. The LOX family proteins are major molecules contributing to matrix cross-linking, which is critical for stiffening cancer tissue.…”
Section: Resultsmentioning
confidence: 99%